Cargando…
Mitochondrial fission – a drug target for cytoprotection or cytodestruction?
Mitochondria are morphologically dynamic organelles constantly undergoing processes of fission and fusion that maintain integrity and bioenergetics of the organelle: these processes are vital for cell survival. Disruption in the balance of mitochondrial fusion and fission is thought to play a role i...
Autores principales: | Rosdah, Ayeshah A., K. Holien, Jessica, Delbridge, Lea M. D., Dusting, Gregory J., Lim, Shiang Y. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4876145/ https://www.ncbi.nlm.nih.gov/pubmed/27433345 http://dx.doi.org/10.1002/prp2.235 |
Ejemplares similares
-
Hydralazine protects the heart against acute ischaemia/reperfusion injury by inhibiting Drp1-mediated mitochondrial fission
por: Kalkhoran, Siavash Beikoghli, et al.
Publicado: (2021) -
A novel small molecule inhibitor of human Drp1
por: Rosdah, Ayeshah A., et al.
Publicado: (2022) -
Mitochondrial Dynamin-Related Protein Drp1: a New Player in Cardio-oncology
por: Deng, Yali, et al.
Publicado: (2022) -
Aminoacyl-tRNA synthetases as drug targets in eukaryotic parasites()
por: Pham, James S., et al.
Publicado: (2013) -
Advances in Cytoprotective Drug Discovery
por: Yurchenko, Ekaterina A., et al.
Publicado: (2023)